TORONTO, Nov. 18, 2013 /CNW/ - EMO CAPITAL CORP (NUVI:OTCBB) - is
excited to announce that the Company has requested a proposal from a
USA based nutriceutical supplement manufacturer for production and
packaging of its ME-4Free capsule.
The manufacturer was founded in 2003 and is a Federal Drug Agency (FDA)
approved and a Good Manufacturing Practices (GMP) certified facility.
All ingredients stocked by the manufacturer are United States
Pharmacopeia (USP) grade, which is the official standards setting
authority for all prescription and over-the-counter medicines, dietary
supplements, and other healthcare products manufactured in the Unites
Concurrent with the production development, the Company will also be
building a reliable distribution worldwide network, thereby positioning
it with a firm position in the health care products industry.
Supplement sales reached $11.5 billion in US in 2012 and are expected to
reach $15.5 billion by 2017. NUVI expects this growing market to
strengthen demand for the ME-4Free capsules and other NUVI products.
ME-4Free is a once-daily capsule for men that delivers a natural and
effective method to maximize their sexual health by boosting
testosterone levels. ME-4Free male enhancement pills are preferred by
users looking for an alternative to prescription pills.
The statements by our officers, and other statements regarding optimism
related to the business, expanding exploration and development
activities and other statements in this press release are
forward-looking statements within the meaning of the Securities
Litigation Reform Act of 1995. Such statements are based on current
expectations, estimates and projections about the Company's business.
Words such as expects, anticipates, intends, plans, believes, sees,
estimates and variations of such words and similar expressions are
intended to identify such forward-looking statements. These statements
are not guarantees of future performance and involve certain risks and
uncertainties that are difficult to predict. Actual results could vary
materially from the description contained herein due to many risk
factors that affect the industry the Company operates in and other risk
factors listed from time to time in the Company's Securities and
Exchange Commission (SEC) filings under "risk factors" and elsewhere.
The forward-looking statements contained in this press release speak
only as of the date on which they are made, and the Company does not
undertake any obligation to update any forward-looking statement to
reflect events or circumstances after the date of this press release.
SOURCE: EMO CAPITAL CORP
For further information:
Telephone: 949 419 6588